Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,341 | -2,930 | -2,071 | -1,344 | -678 |
| Depreciation Amortization | 794 | 657 | 317 | 166 | 55 |
| Accounts payable and accrued liabilities | -62 | 317 | 266 | 328 | 157 |
| Other Working Capital | -80 | 307 | 290 | 283 | 147 |
| Other Operating Activity | 127 | -181 | -180 | -287 | -140 |
| Operating Cash Flow | $-563 | $-1,830 | $-1,379 | $-854 | $-460 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | -1 | -1 | N/A |
| Investing Cash Flow | $N/A | $-1 | $-1 | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 882 | 1,567 | 1,110 | 525 | 200 |
| Other Financing Activity | -6 | -69 | -44 | -4 | 0 |
| Financing Cash Flow | $877 | $1,499 | $1,067 | $522 | $200 |
| Beginning Cash Position | 8 | 341 | 341 | 341 | 341 |
| End Cash Position | 322 | 8 | 28 | 7 | 81 |
| Net Cash Flow | $314 | $-333 | $-313 | $-334 | $-260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -563 | -1,830 | -1,379 | -854 | -460 |
| Capital Expenditure | N/A | -1 | -1 | -1 | N/A |
| Free Cash Flow | -563 | -1,831 | -1,379 | -855 | -460 |